A detailed history of Investors Research Corp transactions in Haleon PLC stock. As of the latest transaction made, Investors Research Corp holds 14,923 shares of HLN stock, worth $145,200. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,923
Previous 14,923 -0.0%
Holding current value
$145,200
Previous $126,000 2.38%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$8.02 - $8.67 $5,012 - $5,418
-625 Reduced 4.02%
14,923 $126,000
Q1 2023

May 11, 2023

SELL
$7.57 - $8.37 $1,892 - $2,092
-250 Reduced 1.58%
15,548 $126,000
Q4 2022

Feb 06, 2023

SELL
$5.96 - $8.06 $745 - $1,007
-125 Reduced 0.79%
15,798 $126,000
Q3 2022

Nov 10, 2022

BUY
$5.63 - $7.5 $89,646 - $119,422
15,923 New
15,923 $97,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.9B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.